Trial intelligence / Profile preview

Ropivacaine Wound Infiltration for Post-Cesarean Analgesia

NCT02579629Phase 4Completed

Sponsor
Emory University
Start
Jul 2015
Primary completion
Jul 2019
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Emory University. Started Jul 2015; status: completed.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02579629.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02579629.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call